Olainfarm Group sales in April increase by 45%

World News: . []

Sales of pharmacy chain of SIA Latvijas Aptieka in April 2019 was close to 2.2 million euros, which represents 11% increase compared to April 2018.  During this period 68 pharmacies operated. Sales of SIA Silvanols in April reached 0.47 million euros, representing increase by 3% vs. the April 2018. Combined sales of Tonus Elast and Elast Medical in April 2019 were 0.8 million euros, which is increase by 2%. Medical centers of Olainmed and Diamed made sales worth 0.28 million euros, while Belarus daughter company NPK Biotest made sales of 0.25 million euros.

During four month of 2019, SIA Latvijas Aptieka sales amounted to 8.7 million euros, demonstrating 12% increase over the same period last year, sales of SIA Silvanols reached 2.1 million euros (an increase by 6%). Combined sales of Tonus Elast and Elast Medical also grew by 6% to 2.9 million euros. Medical centers and NPK Biotest both sold services and products worth over 1.0 million EUR during four months 2019.

According to the budget of JSC Olainfarm, unconsolidated sales of the company in 2019 are planned to reach 99 million euros, while consolidated sales are expected at 133 million euros.  According to these preliminary sales figures, in the first 4 months 2019, 37% of annual target for unconsolidated sales and 35% of annual target for consolidated sales are reached.

Information prepared by:        Jānis DubrovskisInvestor Relations Advisor of JSC OlainfarmPh.: +371 29178878 janis.dubrovskis@olainfarm.com

More news and information about Olainfarm

Published By:

Globe Newswire: 14:05 GMT Wednesday 15th May 2019

Published: .

Search for other references to "olainfarm" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us